1. Bakogeorgos M, Mountzios G, Kotsantis G, Economopoulou P, Fytrakis N. Chemotherapy compliance, tolerance and efficacy in elderly and non-elderly patients with metastatic colorectal cancer: A single institution comparative study. JBUON 2013;18:629–34. (https://www.ncbi.nlm.nih.gov/pubmed/24065475)
2. Balducci L, Extermann M. Management of Cancer in the Older Person: A Practical Approach. The Oncologist 2000;5:224–37. (https://www.ncbi.nlm.nih.gov/pubmed/10884501)
3. Wedding U, Honecker F, Bokemeyer C, Pientka L, Höffken K. Tolerance to Chemotherapy in Elderly Patients with Cancer. Cancer Control 2007;14:44–56. (https://www.ncbi.nlm.nih.gov/pubmed/17242670)
4. Lichtman SM, Villani G. Chemotherapy in the Elderly: Pharmacologic Considerations. Cancer Control 2000;7:548–56. (https://www.ncbi.nlm.nih.gov/pubmed/11088063)
5. Lichtman SM. Guidelines for the Treatment of Elderly Cancer Patients. Cancer Control 2003;10:445–53. (http://journals.sagepub.com/doi/10.1177/107327480301000602)
6. Gironés Sarrió R, Molina Garrido MJ, Guillén-Ponce C, Blanco R, Gonzalez Flores E, Saldaña J. General recommendations paper on the management of older patients with cancer: the SEOM geriatric oncology task force’s position statement. Clin. Transl. Oncol. 2018;20:1246–51. (https://www.ncbi.nlm.nih.gov/pubmed/29633183)
7. Sarfati D, Koczwara B, Jackson C. The impact of comorbidity on cancer and its treatment. CA. Cancer J. Clin. 2016;66:337–50. (https://www.ncbi.nlm.nih.gov/pubmed/26891458)
8. Riechelmann RP, Saad ED. A systematic review on drug interactions in oncology. Cancer Invest. 2006;24:704–12. (https://www.ncbi.nlm.nih.gov/pubmed/17118781)
9. Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly JP, Kearney N, et al. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumors. Eur. J. Cancer Oxf. Engl. 2011;47:8–32. (https://www.ncbi.nlm.nih.gov/pubmed/21095116)
10. Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, et al. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2015;33:3199–212. (https://www.ncbi.nlm.nih.gov/pubmed/26169616)
11. Repetto L, Biganzoli L, Koehne CH, Luebbe AS, Soubeyran P, Tjan-Heijnen VCG, et al. EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer. Eur. J. Cancer Oxf. Engl. 2003;39:2264–72. (https://www.ncbi.nlm.nih.gov/pubmed/14556916)
12. Balducci L, Dolan D, Hoffe SA. Palliative Care in Older Patients with Cancer. Cancer Control J. Moffitt Cancer Cent. 2015;22:480–8. (https://www.ncbi.nlm.nih.gov/pubmed/26678975)